This site is intended for healthcare professionals only
LoginRegister
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia TreatmentAstraZeneca, BioInvent ink pact to evaluate BI-1206 in combo with rituximab, Calquence
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresGSK gets USFDA Fast Track designation for Bepirovirsen in chronic hepatitis B
RocheRoche cutting jobs in product development: Report
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyDr Reddy's Labs gets USFDA EIR for Bachupally facility
Akums Drugs and Pharma files draft IPO papers with SebiAkums Drugs and Pharma files draft IPO papers with Sebi
RocheModify Clinical Study Protocol: CDSCO Panel Tells Roche On Multiple Sclerosis Drug Ocrelizumab
Novartis declares positive results from phase III study for new malaria treatmentCDSCO Panel Approves Novartis Protocol Amendment Proposal For Multiple Sclerosis Drug Ofatumumab
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer CEO says company stands behind glyphosate
Bayer Healthcare backed Metagenomi cuts US IPO valuation target to USD 563 millionBayer Healthcare backed Metagenomi cuts US IPO valuation target to USD 563 million
Jubilant Generics invests Rs 20 lakh in Jubilant Pharma CanadaFireside Ventures leads funding round of Rs 50 crore in Amaha
Zydus Lifesciences reports bigger-than-expected rise in Q3 profitZydus Lifesciences reports bigger-than-expected rise in Q3 profit
Boehringer Ingelheims Vetmedin Becomes First USFDA-Approved Drug to Delay Heart Failure in DogsStudy Safety and Efficacy of Tenecteplase 0.25 mg/kg in Acute Ischemic Stroke: CDSCO Panel Tells...
X